Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
about
EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveCharacterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associatUndifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 proteinInfection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycleThe Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of OncogenesisNucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker.Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.Detection and characterization of Epstein-Barr virus in clinical specimens.
P2860
Q30837949-505533FA-62A5-4E86-8E41-21EA603C1DCFQ33640213-D81112F0-57E8-4212-AA06-C2AC30003529Q33748089-5349820F-CCB6-439D-9B55-1676FF9D2DE0Q33783746-4E49429C-EEE1-4399-BEF2-797D52F1A960Q34502958-DDD4C62F-DE1E-4A78-8216-EC4F2F87FB65Q35115666-8E2EDDD4-AC0E-4136-9631-CAEB6D97BE60Q35147016-DA2716A0-1DCD-4EA1-88E5-64831CDA35A0Q35757197-A811C6D5-DC87-47D4-A25B-2A48977295C4Q35798133-1B0FED3E-AFF6-4C8A-BAE4-CD4092820B3AQ35798521-8615BDCC-4F4C-45EE-97D6-08BA8764B008Q35854017-378FE311-EA32-4299-9794-63405D7535A0Q35871457-18656256-F682-4C24-B6EE-4BA952675C7AQ35872919-2121E606-60B6-4F2F-A006-358F30FB9879Q35874869-2BB75404-E1CE-4520-8E87-677EDBCF99F9Q35892261-9EA78D20-8CE7-43DD-AA04-273B434AAE81Q36327458-2FB2B1B4-013C-476E-AF4F-620C7E3453EFQ38257974-36F7A18C-F357-4B0B-A827-514D67C61524Q39556046-CC0C0BC8-6683-4CFB-A108-2A253110A398Q39581267-0E08AA04-2295-4020-BEFC-9A446E4DB195Q39599529-BDF34913-C52B-4CC1-92D7-866AB2500D5FQ39683197-51CE11DC-01B9-415E-BC57-76EA4422B0CFQ39683879-B7854163-0DDF-4E1D-9D66-F286F61011BCQ39870487-5BD7C3AE-3BC8-4DAD-B944-0350F93AB837Q40041854-E646EA8A-D799-4F72-8FBF-FD4B1EA4225EQ40684609-79D6C794-2C8B-453B-B956-D7C85D6EC1ED
P2860
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
@ast
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
@en
type
label
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
@ast
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
@en
prefLabel
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
@ast
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas
@en
P2093
P2860
P304
P407
P577
1993-10-01T00:00:00Z